These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7946176)

  • 1. Experimental and clinical effects of isradipine relevant to atherosclerosis.
    Bernini F; Soma MR; Corsini A; Paoletti R
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):30S-34S. PubMed ID: 7946176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct antiatherogenic activity of isradipine and lacidipine on neointimal lesions induced by perivascular manipulation in rabbits.
    Donetti E; Fumagalli R; Paoletti R; Soma MR
    Pharmacol Res; 1997 May; 35(5):417-22. PubMed ID: 9299204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study.
    Hansson L; Zanchetti A
    Blood Press; 1995 May; 4(3):133-6. PubMed ID: 7670645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity.
    Hof RP; Rüegg UT
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):107S-113S. PubMed ID: 1826999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic, antivasoconstrictor, and antiatherosclerotic effects of calcium antagonists in animal models of atherosclerosis.
    Hof RP; Tapparelli C; Weinstein DB
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S7-12. PubMed ID: 1695307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of isradipine on the formation and regression of fatty streaks in cholesterol fed rabbits.
    Kunjara-Na-Ayudhya R; Thomson AB; Kappagoda CT
    Cardiovasc Res; 1994 Jul; 28(7):1089-95. PubMed ID: 7954596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant aspirin treatment abolishes the antiatherosclerotic effects of the calcium channel blocker isradipine mediated by PGI2.
    Pirich C; Lupattelli G; Virgolini I; Keiler A; Gerakakis A; Angelberger P; Sinzinger H
    Agents Actions Suppl; 1992; 37():242-50. PubMed ID: 1385925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiatherosclerotic actions of isradipine.
    Sinzinger H; Fitscha P
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S29-31. PubMed ID: 1376831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: II. Effect on regression of atherosclerosis and restoration of endothelial function.
    Riezebos J; Vleeming W; Beems RB; van Amsterdam JG; Meijer GW; de Wildt DJ; Porsius AJ; Wemer J
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):424-31. PubMed ID: 7515986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isradipine: a profile in essential hypertension.
    Hansson L
    Acta Anaesthesiol Scand Suppl; 1993; 99():26-8. PubMed ID: 8480503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral isradipine reduces blood pressure in hypertensive crisis.
    Saragoça MA; Mulinari RA; Oliveira AF; Portela J; Plavnik FL; Melegari D; Ramos OL
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):112S-114S. PubMed ID: 8466719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
    Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: I. Effect on progression of atherosclerosis and endothelial dysfunction.
    Riezebos J; Vleeming W; Beems RB; van Amsterdam JG; Meijer GW; de Wildt DJ; Porsius AJ; Wemer J
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):415-23. PubMed ID: 7515985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
    Borhani NO
    Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
    Grimm RH; Flack JM; Byington R; Bond G; Brugger S
    Drugs; 1990; 40 Suppl 2():38-43. PubMed ID: 2150640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.
    Borhani NO; Mercuri M; Borhani PA; Buckalew VM; Canossa-Terris M; Carr AA; Kappagoda T; Rocco MV; Schnaper HW; Sowers JR; Bond MG
    JAMA; 1996 Sep; 276(10):785-91. PubMed ID: 8769587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium, calcium antagonists and experimental atherosclerosis.
    Paoletti R; Corsini A; Soma MR; Bernini F
    Blood Press Suppl; 1996; 4():12-5. PubMed ID: 8973776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to study the role of hypertension in atherosclerosis. Lessons from MIDAS. Multicentre Isradipine Diuretic Atherosclerosis Study.
    Hansson L
    Blood Press Suppl; 1996; 4():16-9. PubMed ID: 8973777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.
    Schuster S; Doudnikoff E; Rylander D; Berthet A; Aubert I; Ittrich C; Bloch B; Cenci MA; Surmeier DJ; Hengerer B; Bezard E
    Biol Psychiatry; 2009 Mar; 65(6):518-26. PubMed ID: 18947822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonists and atherosclerosis].
    Korzeniewska I; Rewerski W; Członkowski A
    Pol Tyg Lek; 1994 Jun 20-27; 49(25-26):579-82. PubMed ID: 7659615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.